Akila Prashant
- Pharmacology top 10%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
-
- Sepsis Diagnosis and Treatment 5
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Respiratory Support and Mechanisms 4
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
-
- Hemoglobinopathies and Related Disorders 4
-
- Iron Metabolism and Disorders 3
-
- Innovations in Medical Education 3
- Co-authors
- Vivian D’SouzaPraveen KulkarniChandini RangaswamySubbaRao V. MadhunapantulaDivya P. KumarKuzhuvelil B. HarikumarBojan NatarajThuppil Venkatesh
- Cited by
- Applied Microbiology and BiotechnologyPharmacologyCritical Care and Intensive Care Medicine
- Journals
- Frontiers in Pharmacology (3 papers)Molecular Biology Reports (2 papers)Antibiotics (2 papers)
- Partner nations
- IndiaUnited StatesAustralia
In The Last Decade
Akila Prashant
61 papers receiving 543 citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Applied Microbiology and Biotechnology 11
- Pharmacology 47
- Critical Care and Intensive Care Medicine 23
- Biochemistry 23
- Molecular Medicine 19
Countries citing papers authored by Akila Prashant
This map shows the geographic impact of Akila Prashant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akila Prashant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akila Prashant more than expected).
Fields of papers citing papers by Akila Prashant
This network shows the impact of papers produced by Akila Prashant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akila Prashant. The network helps show where Akila Prashant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akila Prashant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | Multidrug-Resistant Sepsis: A Critical Healthcare Challengebreakdown → | 2024 | 57 |
| 7 | 2023 | 7 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 2 | |
| 15 | 2018 | 6 | |
| 16 | 2015 | 0 | |
| 17 | 2014 | 1 | |
| 18 | Exploration of the Clinico-Biochemical Parameters to Explain the Altered Renal Mechanisms in Gestational Diabetes Mellitus | 2012 | 6 |
| 19 | 2012 | 17 | |
| 20 | 2011 | 12 |
About Akila Prashant
Akila Prashant is a scholar working on Family Practice, Endocrinology, Diabetes and Metabolism and Medical Laboratory Technology, having authored 78 papers that have together received 572 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Sepsis Diagnosis and Treatment (5 papers), Respiratory Support and Mechanisms (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Iron Metabolism and Disorders (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Innovations in Medical Education (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (11 citations), Pharmacology (47 citations) and Critical Care and Intensive Care Medicine (23 citations). Akila Prashant has collaborated with scholars based in India, United States and Australia. Frequent co-authors include Vivian D’Souza, Praveen Kulkarni, Chandini Rangaswamy, SubbaRao V. Madhunapantula, Divya P. Kumar, Kuzhuvelil B. Harikumar, Bojan Nataraj, Thuppil Venkatesh, P A Mahesh and Davangere P. Devanand. Their work appears in journals such as Frontiers in Pharmacology, Molecular Biology Reports, Antibiotics, Clinica Chimica Acta and American Journal of Orthodontics and Dentofacial Orthopedics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.